Peter Tobin
Impact in
-
- Drug Transport and Resistance Mechanisms
- Neutropenia and Cancer Infections
- Cancer Treatment and Pharmacology
-
- Oral health in cancer treatment
Papers in
-
- Cancer therapeutics and mechanisms 7
- Oncology 5
- Cancer Treatment and Pharmacology 2
- Drug Transport and Resistance Mechanisms 2
- Lung Cancer Research Studies 1
- Co-authors
- Stephen Clarke (5 shared papers)Rohini Sharma (1 shared paper)Laurent P. Rivory (7 shared papers)David H. Richards (1 shared paper)Corey J. Wilson (1 shared paper)Peter R. Wielinga (1 shared paper)Wendy B. London (1 shared paper)Michelle Haber (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (1 paper)Journal of Pharmacy and Pharmacology (1 paper)Molecular Cancer Therapeutics (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Current Drug Metabolism (1 paper)
- Partner nations
- AustraliaUnited StatesNetherlands
In The Last Decade
Peter Tobin
11 papers receiving 432 citations
Peers
Comparison fields: 5 of 79
- Oncology 166
- Pulmonary and Respiratory Medicine 81
- Molecular Biology 187
- Pharmacology 23
- Toxicology 9
Countries citing papers authored by Peter Tobin
This map shows the geographic impact of Peter Tobin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Tobin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Tobin more than expected).
Fields of papers citing papers by Peter Tobin
This network shows the impact of papers produced by Peter Tobin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Tobin. The network helps show where Peter Tobin may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Tobin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 174 | |
| 2 | 2005 | 111 | |
| 3 | 2005 | 41 | |
| 4 | 2014 | 40 | |
| 5 | 2005 | 30 | |
| 6 | 2003 | 14 | |
| 7 | 2002 | 12 | |
| 8 | 2004 | 10 | |
| 9 | 2004 | 8 | |
| 10 | Shall One Invest in Cancelled Targets after the Termination of Mergers and Acquisitions | 2006 | 3 |
| 11 | 2022 | 1 | |
| 12 | 2005 | 0 |
About Peter Tobin
Peter Tobin is a scholar working on Molecular Biology, Oncology, Surgery, Neurology and Organic Chemistry, having authored 12 papers that have together received 444 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Cancer Treatment and Pharmacology (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Neuroblastoma Research and Treatments (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Lung Cancer Research Studies (1 paper), Nausea and vomiting management (1 paper) and Flood Risk Assessment and Management (1 paper). The work is most often cited by research in Oncology (166 citations), Pulmonary and Respiratory Medicine (81 citations), Molecular Biology (187 citations), Pharmacology (23 citations) and Toxicology (9 citations). Peter Tobin has collaborated with scholars based in Australia, United States and Netherlands. Frequent co-authors include Stephen Clarke, Rohini Sharma, Laurent P. Rivory, David H. Richards, Corey J. Wilson, Peter R. Wielinga, Wendy B. London, Michelle Haber, George L. Scheffer and Glenn M. Marshall. Their work appears in journals such as British Journal of Clinical Pharmacology, Journal of Pharmacy and Pharmacology, Molecular Cancer Therapeutics, Journal of Pharmacology and Experimental Therapeutics and Current Drug Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.